期刊
BIOMATERIALS
卷 31, 期 1, 页码 115-123出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2009.09.032
关键词
PEGylation; PDMAEMA; HIV-1; Vaccine; Vector; Mucosa
资金
- National Natural Science Foundation of China [2008ZX10001-002, 012]
- National Grand Program on Key Infectious Disease Control
- [30772007]
- [30771915]
To minimize the cytotoxicity of poly (2-(dimethylamino) ethyl methacrylate) (PDMAEMA) as a gene delivery vector, we synthesized PEGylated PDMAEMA by atom transfer radical polymerization (ATRP). Here we report its effects on transfection efficiency in vitro delivered with a GFP expression plasmid and immunogenicity in vivo after complexed with a HIV gag gene DNA vaccine. mPEG(113)-b-PDMAEMA(94) Was efficient in condensing DNA and formed polyplexes with an average diameter of about 150 rim. The in vitro transfection experiments demonstrated that PEGylation dramatically decreased the cytotoxicity at the N/P ratios above 30, although the transfection efficiency in vitro was reduced. Interestingly, mice in vivo vaccination study clearly showed that PEGylated PDMAEMA used as DNA delivery vector significantly improved the prime effect of DNA vaccine through intranasal administration. Importantly, PEGylated PDMAEMA was further proved its ability to induce cytokines production by murine macrophages. Overall, mPEG-b-PDMAEMA can be used as an efficient DNA vaccine vector which enhances adaptive immune responses by activating innate immunity. (C) 2009 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据